Market Overview

The Global Colorectal Cancer Screening Market was valued at USD 14,257.9 million in 2023 and is expected to reach USD 26,784.0 million by 2031 while growing at a CAGR of 8.2% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global colorectal cancer screening market growth. Colorectal cancer screening aims to detect the presence of colorectal cancer or precancerous lesions in individuals without symptoms, with the goal of early detection and treatment or prevention by identifying and removing polyps.

The increasing incidence of colorectal cancer, coupled with advances in screening technologies like fecal immunochemical tests (FIT) and stool DNA tests, drives the growth of the colorectal cancer screening market. However, the cost of screening tests and concerns about adverse effects and complications restrict the market's growth.

Furthermore, the global colorectal cancer screening industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Screening Test Analysis

The Global Colorectal Cancer Screening Market is segmented among Stool-Based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Screening Tests, based on Screening Test. In 2023, Colonoscopy accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Colorectal Cancer Screening Market is segmented among Hospitals, Independent Diagnostic Labs, and Other End Users, based on End User. In 2023, Hospitals Independent Diagnostics labs accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Colorectal Cancer Screening Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Polymedco Inc., Eiken Chemical Co. Ltd, Sysmex Corporation, Siemens Healthineers AG, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, and Clinical Genomics Technologies Pty Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Colorectal Cancer Screening Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Colorectal Cancer Screening Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Colorectal Cancer Screening Market Segmentation, By Screening Test

• Global Colorectal Cancer Screening Market Share Analysis, By Screening Test

• Global Colorectal Cancer Screening Market Growth Analysis, By Screening Test

• Global Colorectal Cancer Screening Market Trends, By Screening Test

o Stool-Based Tests

o Colonoscopy

o CT Colonography (Virtual Colonoscopy)

o Flexible Sigmoidoscopy

o Other Screening Tests

6. Global Colorectal Cancer Screening Market Segmentation, By End User

• Global Colorectal Cancer Screening Market Share Analysis, By End User

• Global Colorectal Cancer Screening Market Growth Analysis, By End User

• Global Colorectal Cancer Screening Market Trends, By End User

o Hospitals Independent Diagnostics labs

o Other End Users

7. Global Colorectal Cancer Screening Market Segmentation, By Region

• Global Colorectal Cancer Screening Market Share Analysis, By Region

• Global Colorectal Cancer Screening Market Growth Analysis, By Region

• Global Colorectal Cancer Screening Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Polymedco Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Eiken Chemical Co. Ltd

• Sysmex Corporation

• Siemens Healthineers AG

• Quidel Corporation

• Novigenix SA

• Hemosure Inc.

• Exact Sciences Corp.

• Epigenomics Inc.

• Olympus Corporation

• Clinical Genomics Technologies Pty Ltd.

*Similar analysis will be provided for each company listed above.